Dynamic Technology Lab Private Ltd acquired a new position in shares of Ardent Health, Inc. (NYSE:ARDT - Free Report) in the first quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor acquired 34,144 shares of the company's stock, valued at approximately $469,000.
Several other institutional investors have also modified their holdings of the stock. Point72 Asia Singapore Pte. Ltd. purchased a new stake in shares of Ardent Health during the fourth quarter worth about $27,000. Morse Asset Management Inc acquired a new stake in Ardent Health in the 1st quarter worth about $36,000. Deutsche Bank AG increased its stake in Ardent Health by 1,251.9% during the 4th quarter. Deutsche Bank AG now owns 2,866 shares of the company's stock worth $49,000 after buying an additional 2,654 shares in the last quarter. Quarry LP raised its holdings in shares of Ardent Health by 1,519.4% during the first quarter. Quarry LP now owns 5,020 shares of the company's stock valued at $69,000 after acquiring an additional 4,710 shares during the last quarter. Finally, Y Intercept Hong Kong Ltd purchased a new position in shares of Ardent Health in the first quarter valued at approximately $142,000.
Analyst Ratings Changes
A number of analysts have recently issued reports on the company. UBS Group initiated coverage on Ardent Health in a research note on Wednesday. They issued a "buy" rating and a $17.00 price target on the stock. KeyCorp lowered their target price on shares of Ardent Health from $24.00 to $20.00 and set an "overweight" rating on the stock in a research note on Thursday, August 7th. JPMorgan Chase & Co. reduced their target price on shares of Ardent Health from $18.00 to $15.00 and set a "neutral" rating for the company in a research report on Monday, August 11th. Wall Street Zen upgraded shares of Ardent Health from a "buy" rating to a "strong-buy" rating in a research report on Saturday, August 9th. Finally, Stephens reiterated an "overweight" rating and issued a $21.00 price objective on shares of Ardent Health in a report on Tuesday, May 20th. Nine analysts have rated the stock with a Buy rating, one has given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $19.33.
Check Out Our Latest Stock Report on Ardent Health
Ardent Health Trading Down 1.5%
ARDT stock traded down $0.20 during trading on Friday, reaching $13.07. 286,272 shares of the stock were exchanged, compared to its average volume of 273,954. The company has a current ratio of 2.13, a quick ratio of 2.00 and a debt-to-equity ratio of 0.66. The firm has a market capitalization of $1.87 billion, a price-to-earnings ratio of 7.22, a P/E/G ratio of 5.87 and a beta of 0.30. The business has a 50 day moving average price of $12.31 and a 200-day moving average price of $13.13. Ardent Health, Inc. has a 1 year low of $10.10 and a 1 year high of $20.72.
Ardent Health (NYSE:ARDT - Get Free Report) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.52 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $0.30 by $0.22. Ardent Health had a net margin of 4.11% and a return on equity of 16.66%. The business had revenue of $1.65 billion during the quarter, compared to the consensus estimate of $1.54 billion. Ardent Health has set its FY 2025 guidance at 1.730-2.01 EPS. On average, research analysts predict that Ardent Health, Inc. will post 1.23 earnings per share for the current year.
About Ardent Health
(
Free Report)
Ardent Health Partners, Inc owns and operates a network of hospitals and clinics that provides a range of healthcare services in the United States. It operates acute care hospitals, including rehabilitation hospitals and surgical hospitals. The company was founded in 2001 and is based in Brentwood, Tennessee.
Read More

Before you consider Ardent Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ardent Health wasn't on the list.
While Ardent Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Discover the 10 Best High-Yield Dividend Stocks for 2025 and secure reliable income in uncertain markets. Download the report now to identify top dividend payers and avoid common yield traps.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.